Low serum estradiol concentrations after five days of controlled ovarian hyperstimulation for in vitro fertilization are associated with poor outcome

Fertility and Sterility

Volumn 74, Issue 1, 2000, Pages 63-66

  Khalaf, Yacoub ^a   Taylor, Alison ^a   Braude, Peter ^a  

^a ST THOMAS HOSPITAL   (United Kingdom)

Author keywords

Controlled ovarian stimulation; Estradiol; IVF outcome

Indexed keywords

CHORIONIC GONADOTROPIN; ESTRADIOL; HUMAN MENOPAUSAL GONADOTROPIN; UROFOLLITROPIN;

ADULT; ARTICLE; CONTROLLED STUDY; ECHOGRAPHY; FEMALE; FERTILIZATION IN VITRO; HUMAN; MAJOR CLINICAL STUDY; NIDATION; OOCYTE; OVARY FUNCTION; OVULATION INDUCTION; PREGNANCY RATE; PRIORITY JOURNAL; PROGNOSIS;

CHORIONIC GONADOTROPIN; ESTRADIOL; FEMALE; FERTILIZATION IN VITRO; FOLLICULAR PHASE; HUMANS; MENOTROPINS; OUTCOME ASSESSMENT (HEALTH CARE); OVULATION INDUCTION; PREGNANCY; PROGNOSIS;

EID: 0033919921     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0015-0282(00)00569-0     Document Type: Article

References (12)

1. Jones H.W. Jr, Acosta A., Andrews M.C., Garcia J.E., Jones G.S., Mantzavinos T., et al. The importance of the follicular phase to success and failure in in vitro fertilization. Fertil Steril. 40:1983;317-321.
2. Vargyas J., Marrs R., Kletsky D., Mishell D. Correlation of ultrasound measurement of ovarian follicle size and serum estradiol levels in ovulatory patients following clomiphene citrate for in vitro fertilization. Am J Obstet Gynecol. 144:1982;569-573.
3. Mettler L., Tavmergen E.N. Significance of oestradiol values in IVF-ET under a combined GnRH analogue - desensitization and simultaneous gonadotrophin stimulation for the outcome of pregnancies. Hum Reprod. 4(8:(Suppl):1989;59-64.
4. Phelps J.Y., Levine A.S., Hickman T.N., Zacur H.A., Wallach E.E., Hinton E.L. Day 4 estradiol levels predict pregnancy success in women undergoing controlled ovarian hyperstimulation for IVF. Fertil Steril. 69:1998;1015-1019.
5. van Hoof M.H., Alberda A.T., Huisman G.J., Zeilmaker G.H., Leerentveld R.A. Doubling the human menopausal gonadotrophin dose in the course of an in-vitro fertilization treatment cycle in low responders a randomized study . Hum Reprod. 8:1993;369-373.
6. Forman R.G., Robinson J., Egan D., Ross C., Gosden B., Barlow D.H. Follicular monitoring and outcome of in vitro fertilization in gonadotropin-releasing hormone agonist-treated cycles. Fertil Steril. 55:1991;567-573.
7. Loumaye E., Engrand P., Howles C.M., O'Dea L. Assessment of the role of serum luteinizing hormone and estradiol response to follicle-stimulating hormone on in vitro fertilization treatment outcome. Fertil Steril. 67:1997;889-899.
8. Hershlag A., Asis M.C., Diamond M.P., DeCherney A.H., Lavy G. The predictive value and the management of cycles with low initial estradiol levels. Fertil Steril. 53:1990;1064-1067.
9. Abu-Heija A.T., Yates R.W., Barrett T., Jamieson M.E., Fleming R., Coutts J.R. A comparison of two starting doses of human menopausal gonadotrophin for follicle stimulation in unselected patients for in-vitro fertilization. Hum Reprod. 10:1995;801-803.
10. Danforth D.R. Endocrine and paracrine control of oocyte development. Am J Obstet Gynecol. 172:(2 Pt 2):1995;747-752.
11. Armstrong D.T., Zhang X., Vanderhyden B.C., Khamsi F. Hormonal actions during maturation influence fertilization and early embryonic development. Ann N Y Acad Sci. 626:1991;137-158.
12. McNatty K.P., Smith D.M., Makris A., Osathanondh R., Ryan K.J. The microenvironment of the human antral follicle interrelationships among the steroid levels in antral fluid, the population of granulosa cells, and the status of the oocyte in vivo and in vitro . J Clin Endocrinol Metab. 49:1979;851-860.